Skip to main content

MDxHealth SelectMDx Liquid Biopsy Test

MDxHealth has launched its SelectMDx urine-based test for prostate cancer. SelectMDx for prostate cancer is a proprietary urine-based, molecular diagnostic test that offers a non-invasive method to identify patients at low risk for prostate cancer, the company said. The test will be commercially available in the US as a laboratory developed test.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.